Global Antibody Production Market
The global Antibody Production market was valued at USD 7.42 billion in 2016 and is projected to reach USD 21.04 billion by 2025, growing at a CAGR of 12.28% from 2017 to 2025.
Antibody production is a crucial part of biotechnology and drug development procedures in the R&D departments. With increasing demand of personalized medicine and cases of organ transplantations, the market expected to grow at a high rate during the forecast period.
1. Market Drivers
1.1 Favorable Govt. Regulations such as U.S. Fda Clearance of Therapeutic Mabs
1.2 Increasing Adoption of Targeted Immunotherapy in treatment
1.3 Increase in R&D Expenditure
1.4 Rising Number of Fast Track and Orphan Drug Designations
2. Market Restraints
2.1 Cost Constraints Related to the Adoption of Membrane Filters
1. By End User:
1.1 Pharmaceutical and Biotechnology Companies
1.2 Diagnostic Laboratories
1.3 Research Institutes
2. By Process:
2.1 Upstream Processing
2.2.1 Large-Scale Bioreactors
2.2.2 Single-Use Bioreactors (SUBS)
2.3.2 Reagents and Buffers
2.4 Downstream Processing
2.4.1 Chromatography Instruments
2.4.2 Chromatography Resins
18.104.22.168 Affinity Chromatography Resins
2.5 Ion Exchange (IEX) Chromatography Resins
2.6 Hydrophobic Interaction Chromatography (HIC) Resins
2.7 Multimodal Chromatography Resins
2.8.1 Filtration Systems
2.8.2 Filtration Consumables and Accessories
3. By Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
The major players in the market are as follows:
1. GE Healthcare (A SUBSidiary of General Electric Company)
2. Merck KGAA
3. Thermo Fisher Scientific, Inc.
4. Sartorius AG
5. Pall Corporation (Acquired By Danaher Corporation)
6. Sigma-Aldrich Corporation (Acquired By Merck KGAA)
7. Eppendorf AG
8. Cellab GmbH
9. Integra Biosciences AG
10. Fibercell Systems Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Antibody Productionmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.